The study by Winnepenninckx et al. was limited to melanomas in the vertical growth phase and/or with a thickness of > 1 mm [8] and, notably, in our study, MCM3 expression was found to be prognostic also in the category of thin melanomas. This evidence concerns the gene MCM3 and melanoma.